Company Profile
Alivus Life Sciences develops, manufactures, and markets active pharmaceutical ingredients globally. It offers various APIs, such as olmesartan, telmisartan, solifenacin, sitagliptin, zonisamide, rosuvastatin, amiodarone, ezetimibe, lithium carbonate, oxcarbazepine, mirabegron, atovaquone, etoricoxib, remogliflozin, cabozantinib, and palbociclib for various therapeutic areas
Including cardiovascular disease, central nervous system disorders, diabetes, gastrointestinal health, oncology, pain management, immunosuppressant, respiratory and ophthalmologic agents, urology, and anti-infectives contract development and manufacturing services to a range of multinational corporations and specialty companies.
It exports its products. Founded in 2001 and based in Mumbai, India, the company was formerly known as Glenmark Life Sciences Limited before rebranding in December 2024. Alivus Life Sciences Limited is a subsidiary of Nirma Limited.